$IBM(IBM.US)IBM has been almost absurd lately. I placed my take-profit order around the previous heavy resistance zone, figuring that after such a sharp run the stock would at least pause and digest gains. Instead, it blasted straight through the area and left my order looking far too conservative.

The move feels less like a normal valuation expansion and more like a complete narrative re-rating. A few months ago IBM was still viewed as a slow-growing dividend tech company. Now the market is suddenly treating it as a strategic AI, semiconductor, and quantum infrastructure asset.

Everyone knows there is a policy angle behind the move, especially with Washington becoming increasingly involved in domestic technology and manufacturing initiatives. But the speed of the repricing is what catches people off guard. When a stock goes from being ignored to becoming a favored national champion narrative, traditional resistance levels often stop working the way they normally would.

Maybe the most frustrating part is that the trade was not wrong. The level made sense, the risk management made sense, and the profit was real. Yet watching the stock continue vertically higher afterwards still feels like selling too early. That’s the kind of market we‘re in right now—sometimes the hardest thing isn’t cutting losses, it‘s accepting that a position can keep running long after it already looks expensive.

@Bridge Buzz SG